Literature DB >> 12131576

Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients.

Cecilia Tortajada, Bernardo Pérez-Cuevas, Asuncion Moreno, Esteban Martínez, Jose Mallolas, Felipe García, Eugenia Valls, José M Miró, Esther De Lazzari, José M Gatell.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12131576     DOI： 10.1097/00126334-200207010-00015

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  5 in total

1.  Epidemiology of leishmaniasis in Spain based on hospitalization records (1997-2008).

Authors:  Ruth Gil-Prieto; Stefan Walter; Jorge Alvar; Angel Gil de Miguel
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

Review 2.  Of cattle, sand flies and men: a systematic review of risk factor analyses for South Asian visceral leishmaniasis and implications for elimination.

Authors:  Caryn Bern; Orin Courtenay; Jorge Alvar
Journal:  PLoS Negl Trop Dis       Date:  2010-02-09

Review 3.  The immunology of Leishmania/HIV co-infection.

Authors:  Ifeoma Okwor; Jude Eze Uzonna
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

Review 4.  Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review.

Authors:  Gláucia F Cota; Marcos R de Sousa; Ana Rabello
Journal:  PLoS Negl Trop Dis       Date:  2011-06-07

5.  Epidemiological changes in leishmaniasis in Spain according to hospitalization-based records, 1997-2011: raising awareness towards leishmaniasis in non-HIV patients.

Authors:  Zaida Herrador; Alin Gherasim; B Carolina Jimenez; Maria del sol Granados; Marisol Granados; Juan Victor San Martín; Pilar Aparicio
Journal:  PLoS Negl Trop Dis       Date:  2015-03-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.